Stay updated on Dauno/Cytarabine ± Uproleselan in AML Clinical Trial

Sign up to get notified when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history and removed the government-funding notices along with the older Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-11T16:32:24.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a government-funding notice and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-04T10:53:22.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A new revision entry on 2026-01-21 adds the 'Results Posted' item and introduces color-coded diffs (green for additions, red for deletions) across key sections, along with a 'Show glossary' option. The 2025-10-29 'Results Submitted' entry appears as a deletion in the history.
    Difference
    0.4%
    Check dated 2026-01-28T06:20:03.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added to the page history, replacing the previous v3.3.3 entry.
    Difference
    0.0%
    Check dated 2026-01-14T03:07:20.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The record history shows the status shifted from 'No Results Posted' to 'Results Submitted', indicating that results have been submitted to ClinicalTrials.gov. This marks a substantive update to the study record's results status.
    Difference
    0.0%
    Check dated 2026-01-07T01:21:01.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Footer updates: added 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.
    Difference
    0.0%
    Check dated 2025-12-23T21:07:00.000Z thumbnail image

Stay in the know with updates to Dauno/Cytarabine ± Uproleselan in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.